Vulnerabilities

Vulnerability · CVE-2026-1497

Incorrect resolving of namespaces in composite databases in Neo4j Enterprise edition prior to versions 2026.02 and 5.26.22 can lead to the following scenario: an admin…

Published Mar 11, 2026 · catalog updated Aug 28, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-1497. EPSS is 0.24%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Low2.0
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.24%
Remediation
Advisory link
Affected products
cpe neo4j/neo4j

Incorrect resolving of namespaces in composite databases in Neo4j Enterprise edition prior to versions 2026.02 and 5.26.22 can lead to the following scenario: an admin that intends to give a user an access to a remote database constituent "namespace.name" will inadvertently grant access to any local database or remote alias called "name". If such database or alias doesn't exist when the command is run, the privileges will apply if it's created in the future.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe neo4j/neo4jversion unspecified

How to fix CVE-2026-1497

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-1497. EPSS is 0.24%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-863: Incorrect Authorization. EPSS 0.24%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 11, 2026 · NIST NVD

    Detected

    Incorrect resolving of namespaces in composite databases in Neo4j Enterprise edition prior to versions 2026.02 and 5.26.22 can lead to the following scenario: an admin that intends to give a user an access to a remote database constituent "namespace.name" will inadvertently grant access to any local database or remote alias called "name". If such database or alias doesn't exist when the command is

  2. Aug 28, 2026 · NIST NVD

    Updated

    Incorrect resolving of namespaces in composite databases in Neo4j Enterprise edition prior to versions 2026.02 and 5.26.22 can lead to the following scenario: an admin that intends to give a user an access to a remote database constituent "namespace.name" will inadvertently grant access to any local database or remote alias called "name". If such database or alias doesn't exist when the command is

Sources

  • CVE.orgVulnerability recordCVE-2026-1497

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-1497

    30-day exploitation probability 0.2%

    first.org
  • NIST NVDVulnerability recordCVE-2026-1497

    Incorrect resolving of namespaces in composite databases in Neo4j Enterprise edition prior to versions 2026.02 and 5.26.22 can lead to the following scenario: an admin that intends to give a user an access to a remote database constituent "namespace.name" will inadvertently gran

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.